IBIS-II
The IBIS-II (International Breast cancer Intervention Study II) trial is a randomised controlled trial investigating whether anastrozole can help prevent breast cancer in women who are at high risk of the disease. The CPTU is responsible for the management of over 200 sites worldwide, actively recruiting to the trial. Sample size= 10,000
